Form 8-K - Current report:
SEC Accession No. 0001171843-21-004741
Filing Date
2021-07-06
Accepted
2021-07-06 17:08:26
Documents
14
Period of Report
2021-07-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_070621.htm   iXBRL 8-K 14739
2 PRESS RELEASE exh_991.htm EX-99.1 4686
  Complete submission text file 0001171843-21-004741.txt   216502

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3069
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25640
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_070621_htm.xml XML 2894
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 211075009
SIC: 2834 Pharmaceutical Preparations